Xiao-yong Huang

Pemigatinib in previously treated Chinese patients with locally advanced or metastatic cholangiocarcinoma carrying FGFR2 fusions or rearrangements: A phase II study

Xia Li, Haifeng Zhao, Jia Fan, 2022, Cancer medicine.

IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma

Q. Gao, Zheng Wang, Quan-lin Li, 2011, Molecular Cancer.